132 related articles for article (PubMed ID: 17048536)
1. Surface-modified and conventional nanocapsules as novel formulations for parenteral delivery of halofantrine.
Mosqueira VC; Legrand P; Barratt G
J Nanosci Nanotechnol; 2006; 6(9-10):3193-202. PubMed ID: 17048536
[TBL] [Abstract][Full Text] [Related]
2. Interactions between a macrophage cell line (J774A1) and surface-modified poly (D,L-lactide) nanocapsules bearing poly(ethylene glycol).
Mosqueira VC; Legrand P; Gref R; Heurtault B; Appel M; Barratt G
J Drug Target; 1999; 7(1):65-78. PubMed ID: 10614816
[TBL] [Abstract][Full Text] [Related]
3. Poly(D,L-lactide) nanocapsules prepared by a solvent displacement process: influence of the composition on physicochemical and structural properties.
Mosqueira VC; Legrand P; Pinto-Alphandary H; Puisieux F; Barratt G
J Pharm Sci; 2000 May; 89(5):614-26. PubMed ID: 10756327
[TBL] [Abstract][Full Text] [Related]
4. [Long circulating nanocapsules: interest in the treatment of severe malaria with halofantrine].
Legrand P; Mosqueira V; Loiseau P; Bories C; Barratt G
Ann Pharm Fr; 2003 May; 61(3):196-202. PubMed ID: 12714932
[TBL] [Abstract][Full Text] [Related]
5. Effect of polyethylene glycol (PEG) chain organization on the physicochemical properties of poly(D, L-lactide) (PLA) based nanoparticles.
Essa S; Rabanel JM; Hildgen P
Eur J Pharm Biopharm; 2010 Jun; 75(2):96-106. PubMed ID: 20211727
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and pharmacokinetics of intravenous nanocapsule formulations of halofantrine in Plasmodium berghei-infected mice.
Mosqueira VC; Loiseau PM; Bories C; Legrand P; Devissaguet JP; Barratt G
Antimicrob Agents Chemother; 2004 Apr; 48(4):1222-8. PubMed ID: 15047523
[TBL] [Abstract][Full Text] [Related]
7. Biodistribution of long-circulating PEG-grafted nanocapsules in mice: effects of PEG chain length and density.
Mosqueira VC; Legrand P; Morgat JL; Vert M; Mysiakine E; Gref R; Devissaguet JP; Barratt G
Pharm Res; 2001 Oct; 18(10):1411-9. PubMed ID: 11697466
[TBL] [Abstract][Full Text] [Related]
8. Effect of aqueous solubility of grafted moiety on the physicochemical properties of poly(d,l-lactide) (PLA) based nanoparticles.
Essa S; Rabanel JM; Hildgen P
Int J Pharm; 2010 Mar; 388(1-2):263-73. PubMed ID: 20060450
[TBL] [Abstract][Full Text] [Related]
9. Cardiotoxicity reduction induced by halofantrine entrapped in nanocapsule devices.
Leite EA; Grabe-Guimarães A; Guimarães HN; Machado-Coelho GL; Barratt G; Mosqueira VC
Life Sci; 2007 Mar; 80(14):1327-34. PubMed ID: 17303179
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticles of poly(D,L-lactide)/methoxy poly(ethylene glycol)-poly(D,L-lactide) blends for controlled release of paclitaxel.
Dong Y; Feng SS
J Biomed Mater Res A; 2006 Jul; 78(1):12-9. PubMed ID: 16596586
[TBL] [Abstract][Full Text] [Related]
11. Production of insulin-loaded poly(ethylene glycol)/poly(l-lactide) (PEG/PLA) nanoparticles by gas antisolvent techniques.
Elvassore N; Bertucco A; Caliceti P
J Pharm Sci; 2001 Oct; 90(10):1628-36. PubMed ID: 11745721
[TBL] [Abstract][Full Text] [Related]
12. Physical Characterization of Halofantrine-Encapsulated Fat Nanoemulsions.
Haidar I; Harding IH; Bowater IC; McDowall AW
J Pharm Sci; 2019 Jun; 108(6):2153-2161. PubMed ID: 30703385
[TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of biodegradable poly(l-lactide)/poly(ethylene glycol) microcapsules containing erythromycin by emulsion solvent evaporation technique.
Park SJ; Kim SH
J Colloid Interface Sci; 2004 Mar; 271(2):336-41. PubMed ID: 14972610
[TBL] [Abstract][Full Text] [Related]
14. Relationship between complement activation, cellular uptake and surface physicochemical aspects of novel PEG-modified nanocapsules.
Mosqueira VC; Legrand P; Gulik A; Bourdon O; Gref R; Labarre D; Barratt G
Biomaterials; 2001 Nov; 22(22):2967-79. PubMed ID: 11575471
[TBL] [Abstract][Full Text] [Related]
15. Release profiles and morphological characterization by atomic force microscopy and photon correlation spectroscopy of 99mTechnetium-fluconazole nanocapsules.
de Assis DN; Mosqueira VC; Vilela JM; Andrade MS; Cardoso VN
Int J Pharm; 2008 Feb; 349(1-2):152-60. PubMed ID: 17869460
[TBL] [Abstract][Full Text] [Related]
16. The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles.
Zhang Z; Feng SS
Biomaterials; 2006 Jul; 27(21):4025-33. PubMed ID: 16564085
[TBL] [Abstract][Full Text] [Related]
17. Effect of polymer architecture on surface properties, plasma protein adsorption, and cellular interactions of pegylated nanoparticles.
Sant S; Poulin S; Hildgen P
J Biomed Mater Res A; 2008 Dec; 87(4):885-95. PubMed ID: 18228249
[TBL] [Abstract][Full Text] [Related]
18. Folate-conjugated amphiphilic star-shaped block copolymers as targeted nanocarriers.
Zhu J; Zhou Z; Yang C; Kong D; Wan Y; Wang Z
J Biomed Mater Res A; 2011 Jun; 97(4):498-508. PubMed ID: 21509931
[TBL] [Abstract][Full Text] [Related]
19. PLA-PEG nanocapsules radiolabeled with 99mTechnetium-HMPAO: release properties and physicochemical characterization by atomic force microscopy and photon correlation spectroscopy.
Pereira MA; Mosqueira VC; Vilela JM; Andrade MS; Ramaldes GA; Cardoso VN
Eur J Pharm Sci; 2008 Jan; 33(1):42-51. PubMed ID: 17983736
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of fenofibrate-loaded PLA-PEG microspheres.
Ren J; Yu X; Ren T; Hong H
J Mater Sci Mater Med; 2007 Aug; 18(8):1481-7. PubMed ID: 17387589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
